SARS-CoV-2 Nucleoprotein, 222-230

Description:

This peptide is derived from severe acute respiratory syndrome coronavirus 2(SARS-Cov-2), Nucleoprotein(Uniprot No: P0DTC9). Antigen Peptide LLLDRLNQL, probable allele specificity HLA-A*02:01, for stimulation of antigen-specific T cells in T cell assays.

Sequence:

LLLDRLNQL

General

References

Comments (0)

Name	SARS-CoV-2 Nucleoprotein, 222-230
Category	COVID-19
One Letter Code	LLLDRLNQL
Three Letter Code	{LEU}{LEU}{LEU}{ASP}{ARG}{LEU}{ASN}{GLN}{LEU}
Molecular Weight	1097.310
Application	T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response

1. Grifoni, Alba, et al. "A sequence homology and bioinformatic approach can predict candidate targets for immune responses to SARS-CoV-2." Cell host & microbe (2020).

2. Lee, Chloe Hyun-Jung, and Hashem Koohy. "In silico identification of vaccine targets for 2019-nCoV." F1000Research 9 (2020).